Azimzade Y, Haugen MH, Kristensen VN, Frigessi A, Köhn-Luque A(2026) Explainable machine learning-guided integrated multiomics analysis reveals macrophage-driven immune suppression in breast cancer Nat Commun(in press) DOI 10.1038/s41467-026-73617-9, PubMed 42185288
Torland LA, Geisler J, Azimzade Y, Frafjord A, Røed Nilsen H, Buer L, Lømo J, Garred Ø, Tahiri A, Lyngra M, Øynebråten I, Corthay A, Sahlberg K, Kristensen V, Tekpli X(2026) Multi-platform analysis of the tumor immune microenvironment associated with breast cancer subtypes Oncoimmunology, 15(1), 2610535 DOI 10.1080/2162402X.2025.2610535, PubMed 41530924
Billaud A, Figlioli G, Mooser C, Casamassima I, Azzoni V, Srivatsa J, Colombo M, Caleca L, Ahearn TU, Andrulis IL, Antoniou AC, Beckmann MW, Behrens S, Bermisheva M, Bogdanova NV, Bolla MK, Bonanni B, Brüning T, Camp NJ, Campbell A, Castelao JE, Cessna MH, Chang-Claude J, NBCS Collaborators, Czene Ket al.(2025) Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer Breast, 85, 104619 DOI 10.1016/j.breast.2025.104619, PubMed 41223770
